Coreline AI Coronary Artery Calcium Solution Shows 99.2% Accuracy From a Population Study
SEOUL, South Korea--(BUSINESS WIRE)--#AICACSolution--Coreline Soft, the developer of the AI Coronary Artery Calcium (CAC) solution…
4 years ago
Fibocom Launches the 5G AIoT Commercialized Products Handbook, Exploring New 5G Values
SHENZHEN, China--(BUSINESS WIRE)--#5G--Fibocom, together with China Mobile, China Telecom, China Unicom, Qualcomm, UNISOC, MediaTek and…
4 years ago
India Monoclonal Antibodies Markets Analysis, Forecast & Opportunities, 2016-2020 & 2021-2026 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "India Monoclonal Antibodies Market, By Type (Murine, Chimeric, Humanized, Human), By Application (Cancer,…
4 years ago
Havas Group Continues Rapid Expansion of Red Havas
Red Havas rolls out to Germany, Spain, China, Italy and France, adding to existing bench…
4 years ago
Taoglas and Bigbelly Team up at Mobile World Congress LA to Showcase Multi-Purpose Smart City Platform for Deploying Small Cells
LOS ANGELES--(BUSINESS WIRE)--#BigBelly--MOBILE WORLD CONGRESS -- Taoglas®, a leading enabler of digital transformation through IoT,…
4 years ago
Firstsource and Eco-Mail Partner to Strengthen Workflow Digitization for Health Plans Amidst Permanent Shift to a Remote Workforce
Collaboration to Extend Firstsource’s Best-in-Class Digital Intake Capabilities MUMBAI, India & LOUISVILLE, Ky.--(BUSINESS WIRE)--Firstsource Solutions…
4 years ago
VavaCars raises $50 million in Series B to build presence in Turkey and Pakistan
ISTANBUL, TURKEY - G MEDYA - 26 October 2021 - VavaCars, a Turkey-based online trading…
4 years ago
Wellteq Digital Health Inc. Partners With Top Global University to Commercialise Sleep Research
Wellteq Digital Health Inc. (CSE: WTEQ / OTCQB: WTEQF) has signed a Letter of Intent…
4 years ago
Rakuten Symphony, Intel and Juniper Networks Introduce Next Generation Distributed RAN and Transport Solution to Further Simplify Open RAN Deployments at Scale
The solution slashes the total cost of ownership and fast-tracks innovations in the radio access…
4 years ago
First Patient Dosed in CANbridge Pharmaceuticals CAN008 Phase 2 Trial for Treatment of Glioblastoma Multiforme (GBM) in China
BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--CANbridge Pharmaceuticals, Inc., a leading China-based global rare disease-focused biopharmaceutical company…
4 years ago